However, based on the comparison of the tumor infiltration by FCM and the percentage of cells carrying MYD88 mutation by single-cell analysis, we were able to confirm that this alteration can be present in phenotypically normal B cells of WM patients (Rodriguez et al., 2022). Here, MYD88 is linked to neoplasm.